What is Oncovia™? 30+ Oncovia™ (Lumetrexan) is a precision-targeted therapy developed to combat advanced non-small cell lung cancer (NSCLC). Designed to selectively inhibit tumor growth while preserving healthy cells, Oncovia™ delivers superior efficacy with fewer side effects than traditional treatments. Available countries, bringing hope to millions. 68% proven increase in survival rates.